HRP20120912T1 - Derivati kinolina kao antibakterijska sredstva - Google Patents

Derivati kinolina kao antibakterijska sredstva Download PDF

Info

Publication number
HRP20120912T1
HRP20120912T1 HRP20120912TT HRP20120912T HRP20120912T1 HR P20120912 T1 HRP20120912 T1 HR P20120912T1 HR P20120912T T HRP20120912T T HR P20120912TT HR P20120912 T HRP20120912 T HR P20120912T HR P20120912 T1 HRP20120912 T1 HR P20120912T1
Authority
HR
Croatia
Prior art keywords
alkyl
use according
compound
image
formula
Prior art date
Application number
HRP20120912TT
Other languages
English (en)
Croatian (hr)
Inventor
Koenraad J.L.M. Andries
Anil Koul
Jérôme E.G. GUILLEMONT
David F.A. LANÇOIS
Magali M.S. Motte
Ismet Dorange
Leo J. J. Backx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34940244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20120912(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HRP20120912T1 publication Critical patent/HRP20120912T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HRP20120912TT 2005-06-28 2006-06-26 Derivati kinolina kao antibakterijska sredstva HRP20120912T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05105762 2005-06-28
PCT/EP2006/063553 WO2007000435A1 (en) 2005-06-28 2006-06-26 Quinoline derivatives as antibacterial agents

Publications (1)

Publication Number Publication Date
HRP20120912T1 true HRP20120912T1 (hr) 2012-12-31

Family

ID=34940244

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120912TT HRP20120912T1 (hr) 2005-06-28 2006-06-26 Derivati kinolina kao antibakterijska sredstva

Country Status (31)

Country Link
US (1) US8841321B2 (enExample)
EP (1) EP1898914B1 (enExample)
JP (1) JP5193858B2 (enExample)
KR (1) KR101329585B1 (enExample)
CN (1) CN101247811B (enExample)
AP (1) AP2386A (enExample)
AR (1) AR054626A1 (enExample)
AU (1) AU2006263883B2 (enExample)
BR (1) BRPI0612498A8 (enExample)
CA (1) CA2612619C (enExample)
CY (1) CY1113579T1 (enExample)
DK (1) DK1898914T3 (enExample)
EA (1) EA014423B1 (enExample)
ES (1) ES2393203T3 (enExample)
HR (1) HRP20120912T1 (enExample)
IL (1) IL188393A0 (enExample)
JO (1) JO2752B1 (enExample)
ME (1) ME01484B (enExample)
MX (1) MX2008000081A (enExample)
MY (1) MY153291A (enExample)
NO (1) NO342701B1 (enExample)
NZ (1) NZ564379A (enExample)
PA (1) PA8683801A1 (enExample)
PL (1) PL1898914T3 (enExample)
PT (1) PT1898914E (enExample)
RS (1) RS52517B (enExample)
SI (1) SI1898914T1 (enExample)
TW (1) TWI387457B (enExample)
UA (1) UA92175C2 (enExample)
WO (1) WO2007000435A1 (enExample)
ZA (1) ZA200711165B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
CN104254527B (zh) 2012-04-27 2017-05-31 詹森药业有限公司 抗菌的喹啉衍生物
AU2013254670B2 (en) 2012-04-27 2017-03-30 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
EP3237383B1 (en) 2014-12-23 2019-12-04 Albemarle Corporation One-step process for the synthesis of alkylated metyrapone analogs
CN106928139B (zh) * 2017-05-08 2019-06-25 福建省微生物研究所 一种贝达喹啉杂质的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DK2301544T3 (da) 2002-07-25 2013-01-02 Janssen Pharmaceutica Nv Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer
SI1675852T1 (sl) 2003-09-22 2009-06-30 Janssen Pharmaceutica Nv 7-amino alkilidenil-heterociklični kinoloni in naftiridoni
EP1753427B1 (en) * 2004-05-28 2008-04-02 Janssen Pharmaceutica N.V. Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
DK1898909T3 (en) 2005-06-28 2017-02-06 Janssen Pharmaceutica Nv QUINOLIN DERIVATIVES AS ANTIBACTERIAL AGENTS

Also Published As

Publication number Publication date
CY1113579T1 (el) 2016-06-22
SI1898914T1 (sl) 2013-01-31
PA8683801A1 (es) 2007-01-17
EA014423B1 (ru) 2010-12-30
US20100048585A1 (en) 2010-02-25
BRPI0612498A8 (pt) 2018-01-02
KR20080021156A (ko) 2008-03-06
IL188393A0 (en) 2008-08-07
US8841321B2 (en) 2014-09-23
ME01484B (me) 2014-04-20
MY153291A (en) 2015-01-29
NZ564379A (en) 2010-11-26
ES2393203T3 (es) 2012-12-19
KR101329585B1 (ko) 2013-11-15
JP2008543964A (ja) 2008-12-04
AU2006263883B2 (en) 2012-12-13
TW200740437A (en) 2007-11-01
ZA200711165B (en) 2011-05-25
JP5193858B2 (ja) 2013-05-08
CA2612619C (en) 2015-12-01
AP2386A (en) 2012-03-23
RS52517B (sr) 2013-04-30
DK1898914T3 (da) 2012-11-26
MX2008000081A (es) 2008-03-24
EP1898914A1 (en) 2008-03-19
NO20080501L (no) 2008-02-28
BRPI0612498A2 (pt) 2010-11-23
PT1898914E (pt) 2012-11-20
UA92175C2 (ru) 2010-10-11
EP1898914B1 (en) 2012-08-15
CN101247811B (zh) 2013-01-02
CA2612619A1 (en) 2007-01-04
NO342701B1 (no) 2018-07-09
HK1122730A1 (en) 2009-05-29
EA200800154A1 (ru) 2008-10-30
WO2007000435A1 (en) 2007-01-04
CN101247811A (zh) 2008-08-20
AR054626A1 (es) 2007-07-04
PL1898914T3 (pl) 2013-01-31
JO2752B1 (en) 2014-03-15
TWI387457B (zh) 2013-03-01
AU2006263883A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
HRP20131116T1 (hr) Derivati kinolina kao antibakterijska sredstva
HRP20160585T1 (hr) Antibakterijski derivati kinolina
ME01207B (me) Derivati hinolina za tretiranje latentne tuberkuloze
JP2009503024A5 (enExample)
HRP20140206T1 (hr) Derivati kinolina kao antibakterijska sredstva
CA2566544A1 (en) Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
AR040673A1 (es) Inhibidores micobacterianos, composicion farmaceutica y proceso de preparacion del compuesto
ME02203B (me) Hinolin i hinoksalin derivati kao inhibitori kinaza
JP2010511668A5 (enExample)
JP2009503025A5 (enExample)
HRP20141108T1 (hr) Antagonisti piperidinon karboksamid azaindan cgrp receptora
HRP20100428T1 (hr) Antibakterijski derivati kvinolina
JP2010511667A5 (enExample)
NZ595448A (en) Hydroxythienoquinolones and related compounds as anti-infective agents
ATE495174T1 (de) 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydroindolizin-3 yl)acetamidderivate und verwandte verbindungen als antipilzmittel
TW200744595A (en) Quinoline derivatives as antibacterial agents
HRP20120912T1 (hr) Derivati kinolina kao antibakterijska sredstva
ME01245B (me) Antibakterijski hinolinski derivati
JP2010511671A5 (enExample)
HRP20120910T1 (hr) Derivati kinolina kao antibakterijska sredstva
HRP20170044T1 (hr) Derivati kinolina kao antibakterijska sredstva
JP2010511670A5 (enExample)
HRP20161704T1 (hr) Derivati kinolina kao antibakterijska sredstva
JP2008546824A5 (enExample)
JP2009503021A5 (enExample)